Mingyang Shan, PhD

Senior Research Scientist
Eli Lilly and Company
Indianapolis, Indiana, United States

Eli Lilly and Company (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)

Presentation(s):

• Using Bias Correction Methods with Hybrid Randomized Controlled Trial (RCT) Plus Real World (RW) Controls to Replicate Results of a Phase Iib RCT of Baricitinib for Rheumatoid Arthritis (RA)

  Friday, August 26, 2022
  1:30 PM - 1:45 PM CEST